logo
Mapmygenome Acquires Microbiome Insights to Boost Global Genomics Reach

Mapmygenome Acquires Microbiome Insights to Boost Global Genomics Reach

Entrepreneur29-05-2025
The acquisition also enables Mapmygenome to introduce its integrated genomics and microbiome testing to North America, providing accessible, data-driven health solutions across borders.
You're reading Entrepreneur India, an international franchise of Entrepreneur Media.
In a move set to redefine personalised health and microbial research, Mapmygenome, an AI-driven leader in genomics, has announced the strategic acquisition of Microbiome Insights, a Canadian pioneer in microbiome sequencing.
The deal includes Microbiome Insights' CAP-accredited laboratory and a valuable portfolio of intellectual property, significantly enhancing Mapmygenome's scientific capabilities and global reach.
With over 1,000 studies completed for 600+ clients globally, Microbiome Insights is a trusted partner for academic, clinical, and industrial research. The company, co-founded by microbiome experts Dr Brett Finlay, Dr William Mohn, and Malcolm Kendall, will continue to operate as a premier contract research organization (CRO), supporting innovation in microbial science.
"The human microbiome is pivotal to health, and this acquisition positions us as a leader in this area," said Anu Acharya, Founder and CEO of Mapmygenome. "We gain exceptional expertise in metagenomics, transcriptomics, and targeted metabolomics to serve academic, biotech, and clinical sectors. This accelerates our North American footprint, aligning with our strategic vision of growth through targeted acquisitions leading up to our listing on the Indian market later this year."
The acquisition also enables Mapmygenome to introduce its integrated genomics and microbiome testing to North America, providing accessible, data-driven health solutions across borders.
"Joining forces with Mapmygenome provides the resources and capabilities to offer higher quality services to our clients and accelerate growth," said Malcolm Kendall, CEO of Microbiome Insights. "Our combined strengths will deliver a new standard of cutting-edge services for clients worldwide."
Financial terms of the deal were not disclosed. The partnership marks a pivotal moment in the convergence of genomics, microbiome science, and AI for global health innovation.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cory Morgan: Cities Should Halt Electric Bus Purchases Given Their Abysmal Track Record
Cory Morgan: Cities Should Halt Electric Bus Purchases Given Their Abysmal Track Record

Epoch Times

time2 hours ago

  • Epoch Times

Cory Morgan: Cities Should Halt Electric Bus Purchases Given Their Abysmal Track Record

While the political battle rages on over mandates for consumer purchases of electric vehicles, Canadian municipalities have been going all-in on electric buses, and it hasn't gone well. Despite the failures of electric bus fleets in numerous North American cities, local governments continue to commit to large-scale electric bus purchases. Calgary's recent commitment to spend nearly half a billion dollars on a fleet of electric buses is one of the latest and largest expenditures in Canada.

U.S. delegation's India visit reportedly called off as trade tensions simmer
U.S. delegation's India visit reportedly called off as trade tensions simmer

CNBC

time5 hours ago

  • CNBC

U.S. delegation's India visit reportedly called off as trade tensions simmer

A scheduled visit by U.S. trade representatives to New Delhi later this month has been called off, according to Indian news broadcaster NDTV Profit. The visit that was expected to take place between Aug. 25 and Aug. 29 will likely be rescheduled, NDTV reported, citing people familiar with the matter. The report comes at a time when trade relations between the two countries have soured with U.S. President Donald Trump imposing a 25% blanket tariff on Indian exports, and topping those with another 25% duties — expected to come into effect on Aug. 27 — as a "penalty" for India purchasing Russian crude. Both sides are in contact with each other, but a new schedule for talks not been finalized, the report said. Trump's cumulative 50% tariff rate on India is among the highest on any of the U.S.' trading partners, and has drawn a sharp response from New Delhi. India has said it was being targeted unfairly, while calling out the EU and the U.S. on their continuing trade with Russia. "It is revealing that the very nations criticizing India are themselves indulging in trade with Russia. Unlike our case, such trade is not even a vital national compulsion [for them]," the country's foreign ministry said in a statement earlier this month. India's Ministry of Commerce and Industry, and the Office of the U.S Trade Representative did not immediately respond to CNBC's request for comments. The U.S. is India's single largest export partner, with nearly 20% of its overall exports, or $86.51 billion worth of goods, shipped to the U.S. in fiscal year ended March 2025, according to the latest official data. Read the full NDTV story here.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store